Martine Vercammen

1.9k total citations · 1 hit paper
32 papers, 1.4k citations indexed

About

Martine Vercammen is a scholar working on Radiology, Nuclear Medicine and Imaging, Epidemiology and Hematology. According to data from OpenAlex, Martine Vercammen has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Epidemiology and 8 papers in Hematology. Recurrent topics in Martine Vercammen's work include Monoclonal and Polyclonal Antibodies Research (9 papers), Toxoplasma gondii Research Studies (8 papers) and Herpesvirus Infections and Treatments (7 papers). Martine Vercammen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (9 papers), Toxoplasma gondii Research Studies (8 papers) and Herpesvirus Infections and Treatments (7 papers). Martine Vercammen collaborates with scholars based in Belgium, France and Netherlands. Martine Vercammen's co-authors include Hendrik Verschueren, Jos De Braekeleer, W. L. Homan, Eric Saman, Dirk Jacobs, Tatiana Scorza, Kris Huygen, H. Van de Velde, Vera Rebmann and Peter A. Horn and has published in prestigious journals such as The Journal of Immunology, Infection and Immunity and Diabetologia.

In The Last Decade

Martine Vercammen

31 papers receiving 1.3k citations

Hit Papers

Identification of a 200- ... 2000 2026 2008 2017 2000 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martine Vercammen Belgium 14 972 716 240 212 163 32 1.4k
P Pouletty France 10 703 0.7× 563 0.8× 217 0.9× 138 0.7× 143 0.9× 19 1.1k
Jolanda D.F. de Groot-Mijnes Netherlands 21 370 0.4× 576 0.8× 107 0.4× 65 0.3× 83 0.5× 42 1.7k
V A Sundqvist Sweden 20 196 0.2× 1.0k 1.4× 377 1.6× 242 1.1× 156 1.0× 37 1.4k
Kirk D.C. Jensen United States 14 871 0.9× 682 1.0× 717 3.0× 83 0.4× 229 1.4× 24 1.6k
Corinna La Rosa United States 25 182 0.2× 1.2k 1.7× 573 2.4× 294 1.4× 207 1.3× 53 1.7k
Michael A. McVoy United States 31 396 0.4× 1.9k 2.6× 352 1.5× 138 0.7× 307 1.9× 94 2.2k
Lesley Pesnicak United States 24 159 0.2× 927 1.3× 444 1.9× 237 1.1× 147 0.9× 38 1.4k
Mustafa Akkoyunlu United States 20 272 0.3× 282 0.4× 498 2.1× 28 0.1× 116 0.7× 42 1.1k
Franck J. D. Mennechet France 17 296 0.3× 365 0.5× 486 2.0× 61 0.3× 318 2.0× 31 1.2k
Jürgen Podlech Germany 30 432 0.4× 2.2k 3.1× 1.5k 6.2× 140 0.7× 211 1.3× 72 2.7k

Countries citing papers authored by Martine Vercammen

Since Specialization
Citations

This map shows the geographic impact of Martine Vercammen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martine Vercammen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martine Vercammen more than expected).

Fields of papers citing papers by Martine Vercammen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martine Vercammen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martine Vercammen. The network helps show where Martine Vercammen may publish in the future.

Co-authorship network of co-authors of Martine Vercammen

This figure shows the co-authorship network connecting the top 25 collaborators of Martine Vercammen. A scholar is included among the top collaborators of Martine Vercammen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martine Vercammen. Martine Vercammen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kesel, Pieter De, Melissa Cambron, Ludo Vanopdenbosch, et al.. (2024). Inter-assay diagnostic accuracy of cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis. Frontiers in Immunology. 15. 1385231–1385231. 4 indexed citations
2.
Hoovels, Lieve Van, Martine Vercammen, Dries Deeren, et al.. (2022). Serum free light chain analysis: persisting limitations with new kids on the block. Clinical Chemistry and Laboratory Medicine (CCLM). 60(9). 1440–1448.
3.
Hoovels, Lieve Van, Ellen De Langhe, Jan Lenaerts, et al.. (2022). Laboratory evaluation of anti-dsDNA antibodies. Clinica Chimica Acta. 528. 34–43. 17 indexed citations
4.
Bossuyt, Xavier, et al.. (2020). Determination of free light chains: assay-dependent differences in interpretation. Clinical Chemistry and Laboratory Medicine (CCLM). 59(2). e69–e71. 1 indexed citations
5.
Hoovels, Lieve Van, Sofie Schouwers, Stefanie Van den Bremt, et al.. (2018). Analytical performance of the single well titer function of NOVA View®: good enough to omit ANA IIF titer analysis?. Clinical Chemistry and Laboratory Medicine (CCLM). 56(11). 258–261. 12 indexed citations
6.
Bossuyt, Xavier, Michel Delforge, Ben Sprangers, et al.. (2018). Diagnostic thresholds for free light chains in multiple myeloma depend on the assay used. Leukemia. 32(8). 1815–1818. 18 indexed citations
7.
Messiaen, Anne-Sophie, et al.. (2017). Performance Evaluation of Serum Free Light Chain Analysis. American Journal of Clinical Pathology. 147(6). 611–622. 25 indexed citations
8.
Vercammen, Martine, et al.. (2015). Overestimation of free light chain antigen excess rate. Clinica Chimica Acta. 444. 297–302. 7 indexed citations
9.
Vercammen, Martine, Stephan Regenass, Rita Derua, et al.. (2011). Betaine homocysteine methyl transferase 1, a novel auto-antigen associated with anti-Golgi immune reactivity. Clinica Chimica Acta. 413(1-2). 105–108. 8 indexed citations
10.
Verloes, A., H. Van de Velde, Joël LeMaoult, et al.. (2011). HLA-G Expression in Human Embryonic Stem Cells and Preimplantation Embryos. The Journal of Immunology. 186(4). 2663–2671. 54 indexed citations
11.
Vermeersch, Pieter, et al.. (2009). Use of interval-specific likelihood ratios improves clinical interpretation of serum FLC results for the diagnosis of malignant plasma cell disorders. Clinica Chimica Acta. 410(1-2). 54–58. 13 indexed citations
12.
Vercammen, Martine, A. Verloes, Patrick Haentjens, & H. Van de Velde. (2009). Can soluble human leucocyte antigen-G predict successful pregnancy in assisted reproductive technology?. Current Opinion in Obstetrics & Gynecology. 21(3). 285–290. 12 indexed citations
13.
Vercammen, Martine, Jacques Sennesael, Brigitte Velkeniers, et al.. (2007). Diagnostic accuracy of the FIDIS multiplex fluorescent microsphere immunodetection system for anti-extractable nuclear antigen (ENA) antibodies in connective tissue diseases. Clinical Chemistry and Laboratory Medicine (CCLM). 45(4). 505–12. 11 indexed citations
14.
Diltoer, Marc, et al.. (2004). Ketosis and cardiac failure: common signs of a single condition. European Journal of Emergency Medicine. 11(3). 172–175. 3 indexed citations
15.
Scorza, Tatiana, Shanti S. D’Souza, Jos De Braekeleer, et al.. (2002). A GRA1 DNA Vaccine Primes Cytolytic CD8+T Cells To Control AcuteToxoplasma gondiiInfection. Infection and Immunity. 71(1). 309–316. 67 indexed citations
16.
Homan, W. L., Martine Vercammen, Jos De Braekeleer, & Hendrik Verschueren. (2000). Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR1Note: Nucleotide sequence data reported in this paper have been submitted to GenBankTM database with the accession number AF146527 (Toxoplasma gondii genomic repetitive 529 bp fragment).1. International Journal for Parasitology. 30(1). 69–75. 613 indexed citations breakdown →
18.
Gorus, Frans, et al.. (1989). Cell surface antibodies in Type 1 (insulin-dependent) diabetic patients. Diabetologia. 32(8). 618–623. 3 indexed citations
19.
Vercammen, Martine, et al.. (1989). Cell surface antibodies in Type 1 (insulin-dependent) diabetic patients. Diabetologia. 32(8). 611–617. 9 indexed citations
20.
Lissens, Willy, Martine Vercammen, Walter Foulon, et al.. (1987). First trimester prenatal diagnosis of lysosomal storage disease. Study of alpha-L-fucosidase isoenzyme patterns in fetal and maternal tissue.. PubMed. 45(4). 464–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026